Song, Yan http://orcid.org/0000-0002-6729-2672
Du, Ting
Ray, Arghya
Chauhan, Krishan
Samur, Mehmet
Munshi, Nikhil
Chauhan, Dharminder http://orcid.org/0000-0002-5548-6138
Anderson, Kenneth C. http://orcid.org/0000-0002-6418-0886
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50100707, R01CA207237)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 1 August 2020
Revised: 28 November 2020
Accepted: 9 December 2020
First Online: 13 January 2021
Conflict of interest
: K.C.A. is on Advisory board of Celgene, Millenium-Takeda, Gilead, Janssen, Sanofi-Aventis, and Bristol Myers Squibb, and is a Scientific Founder of Oncopep and C4 Therapeutics. D.C. is consultant to Stemline Therapeutic, Inc., Oncopeptide AB, and Equity owner in C4 Therapeutics. The remaining authors declare no conflict of interest.